<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03830970</url>
  </required_header>
  <id_info>
    <org_study_id>REB-18-10-045</org_study_id>
    <nct_id>NCT03830970</nct_id>
  </id_info>
  <brief_title>Dose Effect of Canned Mixed Beans on Blood Cholesterol in Healthy Adults With Elevated Cholesterol</brief_title>
  <official_title>A Dose-response Study to Examine the Cholesterol-lowering Effects of Canned Mixed Beans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guelph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pulse Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bonduelle Company</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Guelph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Bean Study will examine the effects of consuming varying doses of canned mixed beans on
      blood cholesterol levels in healthy adults with elevated blood cholesterol levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Bean Study (TBS) is a a multi-centre, randomized, crossover design study which will
      examine the effects of consuming varying doses of canned mixed beans on fasting serum lipid
      profiles in hypercholesterolemic adults. In a randomized order, all participants will
      complete three 4-week study treatments consuming daily amounts of 1 cup canned mixed beans, ½
      cup canned mixed beans and 1 cup of white rice separated by a 4-week washout period. At the
      start and finish of each treatment period, fasting blood will be collected and analyzed for
      lipids, short chain fatty acids (SCFA), alipoproteins, glucose and insulin. Fecal samples
      will also be collected and analyzed for bile acids, SCFA and gut microbiota. The effect of
      mixed bean consumption on height, body weight and blood pressure will also be examined.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2019</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cholesterol Profile</measure>
    <time_frame>4 weeks</time_frame>
    <description>Total cholesterol, LDL cholesterol and HDL cholesterol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>4 weeks</time_frame>
    <description>Fasting glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>4 weeks</time_frame>
    <description>Fasting insulin</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Apolipoproteins (Apo)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Apo B100 and apo AI</description>
  </other_outcome>
  <other_outcome>
    <measure>Fecal Short Chain Fatty Acids</measure>
    <time_frame>4 weeks</time_frame>
    <description>Acetate, Propionate and Butyrate</description>
  </other_outcome>
  <other_outcome>
    <measure>Fecal bile acids</measure>
    <time_frame>4 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Gut Microbiota</measure>
    <time_frame>4 weeks</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypercholesterolemia</condition>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>1/2 cup canned mixed beans</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of 1/2 cup of canned mixed beans everyday for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 cup canned mixed beans</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of 1 cup of canned mixed beans everyday for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control: White Rice</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Consumption of 1 cup of white rice everyday for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Canned mixed beans</intervention_name>
    <description>Black, navy, pinto, red and white kidney beans</description>
    <arm_group_label>1 cup canned mixed beans</arm_group_label>
    <arm_group_label>1/2 cup canned mixed beans</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>White Rice</intervention_name>
    <description>Minute Rice Long Grain White Rice</description>
    <arm_group_label>Control: White Rice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female adults (≥18 years)

          -  BMI 18.5-35 kg/m2

          -  Hypercholesterolemic (Blood LDL cholesterol &gt;3.0 and &lt;5.0 mmol/L)

        Exclusion Criteria:

          -  Blood triglycerides ≥3.0 mmol/L

          -  Diabetes (fasting blood glucose ≥7.0 mmol/L)

          -  Blood pressure &gt;140/90 mmHg

          -  Major medical conditions

          -  Medical or surgical events requiring hospitalization within the last 3 months

          -  Medication use that would interfere with the study outcomes (e.g. cholesterol-lowering
             medications, diabetes-related medications, steroids). All other medications are okay
             if at a stable (3-month) dose

          -  Antibiotic use within the last 3 months

          -  Tobacco product use (&gt;5 times per week)

          -  Cannabis use during the study

          -  Probiotic supplement use (could do a 1-month washout before study)

          -  Dietary fibre supplement use (could do a 1-month washout before study)

          -  NHPs used for cholesterol lowering or glycemic control. All other NHPs are okay if at
             a stable (3-month) dose.

          -  Pulse consumption &gt;4 servings per week

          -  Food allergy or non-food life-threatening allergy

          -  Pregnant or breastfeeding

          -  Alcohol consumption (&gt;14 drinks/week or &gt;4 drinks/sitting)

          -  Recent or intended significant weight loss or gain (&gt;4 kg in previous 3 months)

          -  National-level or professional athlete

          -  Overnight shift worker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alison M. Duncan, PhD, RD</last_name>
    <phone>519-824-4120</phone>
    <phone_ext>53416</phone_ext>
    <email>amduncan@uoguelph.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katarina Doma, MSc</last_name>
    <phone>519-824-4120</phone>
    <phone_ext>58081</phone_ext>
    <email>kdoma@uoguelph.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Human Nutraceutical Research Unit</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G 2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Tucker, PhD</last_name>
      <phone>519-824-4120</phone>
      <phone_ext>54379</phone_ext>
      <email>aborland@uoguelph.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Glycemic Index Laboratories, Inc</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C2N8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Campbell, MSc, CCRP</last_name>
      <phone>416-861-0506</phone>
      <email>jcampbell@gilabs.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2019</study_first_posted>
  <last_update_submitted>May 1, 2019</last_update_submitted>
  <last_update_submitted_qc>May 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guelph</investigator_affiliation>
    <investigator_full_name>Alison Duncan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Mixed Beans</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

